Search Results for: capital cell

Arcis Biotechnology Crowdfunds on Capital Cell, Seeks £1.75 Million

Arcis Biotechnology is crowdfunding on Capital Cell now having already raised £1.25 million. The company is hoping to raise £1.75 million at a pre-money valuation of £18.2 million. Capital Cell “endorses” this company and has posted the following statement: “Arcis’ technology allows the extraction of… Read More

CEO Daniel Oliver Opines: Spanish Biotech Platform Capital Cell’s Crowdfunding Round & Blockchain Opportunities

Capital Cell recently launched a new self-funding fundraising round to create the first ICO marketplace for health via Blockchain. Seeking to raise €700,000, the Barcelona-based platform has already secured over €882,400 from more than 178 investors. The platform was pre-valued at €5,550,000. “We launched the funding round… Read More

Capital Cell UK Previews Precision Physiological Monitoring Wearable Bodytrak

Since launching CES in early 2017, Bodytrak, a copyrighted in-ear, multi-parameter body monitor and cloud analytics platform, has already secured 70% of its next funding milestone, and is launching on Capital Cell, a dedicated life sciences equity crowdfunding platform based in the UK and Spain… Read More

Life Sciences Crowdfunding Platform Capital Cell Opens to UK Investors

Capital Cell, a crowdfunding platform dedicated to life sciences, announced this week it is officially opening its portal to UK investors. The first four investment opportunities now live on the platform. As previously reported, Capital Cell was founded by Daniel Oliver and based in Barcelona, is the first… Read More

Capital Cell Shortlisted for UK Business Angels Association Investment Award

Capital Cell, reportedly Europe’s first equity crowdfunding platform specializing in life science, has been shortlisted for the Best International Growth Business award at the UK Business Angels Association Investment Awards 2017. Capital Cell has been trading in Spain for just over 2 years, successfully closing 14 life… Read More

Capital Cell UK Officially Launches Investment Crowdfunding in the UK

Born in Spain and shipped to the UK, Capital Cell has officially launched in Great Britain. Capital Cell , founded by Daniel Oliver and based in Barcelona, is the first European equity crowdfunding platform for Biotech projects.  After several successful years of investment crowdfunding in… Read More

Capital Cell Celebrates Bionure’s Recordbreaking Spanish Biotech Crowdfunding Campaign, Plans UK Launch

Bionure, a Spanish biotech company developing a  first-in-class drug for the treatment of multiple sclerosis, is currently 115% overfunding on Capital Cell. With more than €1,100,246 raised, Bionure has broken the record for the highest amount raised on a Spanish life science equity crowdfunding platform. Valued at… Read More

BCN Biotech News: Bionure Overfunding & Nearing 1M€ on Capital Cell

Valued at 9,400,000€, Bionure is overfunding on Capital Cell, raising more than 975,422€ from over 210 investors for 9.27% equity for its neuroprotector and myelin regenerator drug which treat Multiple Sclerosis. Bionure is a biotech-based company that is developing a new drug for the treatment of multiple sclerosis, a… Read More

BCN Biotech Aromics Nears 100K€ Crowdfunding on Capital Cell

Aromics, a privately-owned development stage pharmaceutical company founded in 2005, is based in Barcelona, Spain and focused on developing novel first-in-class therapies for the treatment of human diseases. The company has received the seal of Innovative SME from MINECO and achieved different R&D awards from international,… Read More

Spanish Bioinformatics Firm Era7 Closes Capital Cell Campaign With Nearly €600,000 in Funds

Era7 Bioinformatics, a Spanish company that focuses on the revolution of the Microbiome and providing new solutions to address the problem of antibiotic resistance, announced this week it closed its Capital Cell campaign, which raised nearly €600,000 in funding. As previously reported, Era7 Bioinformatics was… Read More

Igniting a Microbiome Revolution: Era7 Bioinformatics Syncs with Capital Cell

This Capital Cell crowfunding campaign is a unique opportunity to co-invest with an undisclosed VC firm in Era7 Bioinformatics, a Spanish company focused on the revolution of the Microbiome and providing new solutions to address the problem of antibiotic resistance. Era7 Bioinformatics uses its own algorithms… Read More

After CNMV Approval, Spain’s Capital Cell Sets Sights on UK Market and FCA Approval

In late July, Barcelona-based Capital Cell received Comisión Nacional del Mercado de Valores (CNMV) approval to operate as a “Participatory Financing Platform.” This authorization includes the capability to select and publish financing projects and also gives Capital Cell the right to operate as an investment… Read More

Brief: Capital Cell, a Biotech Crowdfunding Platform, Receives Regulatory Approval in Spain

Capital Cell, an investment crowdfunding platform that describes itself as the first European crowdfunding platform for biotech projects, has recieved regulatory approval from the Comisión Nacional del Mercado de Valores (CNMV).  According to a statement on their site, after ten months of audits, interviews and… Read More

Exclusive: Bioprognos CEO Sergio Calleja Discusses Crowdfunding with Spanish Platform Capital Cell

Bioprognos, a Barcelona-based biotech company that seeks to improve both clinical outcomes and quality of life for cancer patients ―as well as other diseases (cardiovascular, neurological or endocrine)― through the development of innovative tools for non-invasive, accurate detection from biomarkers found in a simple blood… Read More

Daniel Oliver Shares Insider View: Capital Cell’s Successful Self-Fund

Capital Cell, the first European equity crowdfunding platform specializing in biotech and life sciences startups and companies, has successfully linked with entrepreneurs and investors on their most recent self-funding round. To date the Barcelona-based equity crowdfunding platform founded in 2015  by CEO Daniel Oliver, who also serves as the president of Asociación Española… Read More

Spanish Biotech Platform Capital Cell Quickly Nears Self-Crowdfunding Campaign Goal; Xavier and Josep Castells Lead Investing Round

Capital Cell is the first European equity crowdfunding platform specializing in biotech and  life sciences startups and companies.  Capital Cell links with entrepreneurs seeking funding with investors who want to invest their money in projects with a high growth potential. To date the Barcelona-based equity crowdfunding platform founded in 2015… Read More

Catalan BioTech ZeClinics Secures Record Funding on Capital Cell, 2015’s Largest Spanish Biotech Crowdfunded Investment

The Catalan company ZeClinics, supported by the University Pompeu Fabra of Barcelona and and Barcelona Biomedicine Research Park (PRBB) reached its crowdfunding campaign goal  on Capital Cell,  a campaign that set the record for the the year’s largest biotech crowdfunding investment in Spain.  The company is prevalued at 1M€.  After 88… Read More

The Great Strength of the British Fintech Community: Chancellor Philip Hammond Says Britain is the Global Capital of Fintech

HM Treasury Publishes Fintech Strategy In a widely anticipated speech today during the midst of UK Fintech Week, Chancellor of the Exchequer Philip Hammond told the audience Britain is the global capital of Fintech and he will do everything he can to maintain this title…. Read More

CataloniaBio Member Cebiotex Crowdequity Round Now Live on CapitalCell: Fighting Pediatric Cancer

Cebiotex, a CataloniaBio member, has launched a new crowdequity campaign to raise €650,000 through CapitalCell in order to ensure its first drug, CEB-01 for post-op treatment of soft-tissue sarcomas, reaches pediatric oncology. The campaign is part of a larger €1.6-million round of funding; since launching, the… Read More

Clínica Dialibre: Spain’s First Diabetes Youth Clinic Quickly Closes in on CapitalCell Crowdfunding Goal

Clínica Dialibre, the first clinic in Spain to specialize in diabetes for children, opened in March 2016 with the mission of setting a milestone in the treatment of diabetes and improving the young patients’ quality of life by personalizing the treatment for each patient. The Clinica… Read More

Send this to a friend